316 related articles for article (PubMed ID: 9627334)
21. Limitations of 131I-MIBG scintigraphy in locating pheochromocytomas.
Gough IR; Thompson NW; Shapiro B; Sisson JC
Surgery; 1985 Jul; 98(1):115-20. PubMed ID: 2861667
[TBL] [Abstract][Full Text] [Related]
22. [Noninvasive screening for pheochromocytoma in patients with an incidentally discovered adrenal mass: usefulness of provocative test with metoclopramide and 131I-metaiodobenzylguanidine scintigraphy].
Yokoyama H; Tsuji Y
Hinyokika Kiyo; 1999 Oct; 45(10):677-80. PubMed ID: 10586357
[TBL] [Abstract][Full Text] [Related]
23. Meta-[131I]iodobenzylguanidine in the scintigraphic evaluation of neural crest tumors.
Zagar I; Han R; Mitrovic S
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):13-6. PubMed ID: 9002742
[TBL] [Abstract][Full Text] [Related]
24. Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas--experience and meta-analysis.
Van Der Horst-Schrivers AN; Jager PL; Boezen HM; Schouten JP; Kema IP; Links TP
Anticancer Res; 2006; 26(2B):1599-604. PubMed ID: 16619578
[TBL] [Abstract][Full Text] [Related]
25. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma.
Tenenbaum F; Lumbroso J; Schlumberger M; Mure A; Plouin PF; Caillou B; Parmentier C
J Nucl Med; 1995 Jan; 36(1):1-6. PubMed ID: 7799058
[TBL] [Abstract][Full Text] [Related]
26. Imaging of adrenal medulla with I-131-mIBG. Clinical experience in 208 cases.
Zhu RS; Ma JX; Xu JQ
Chin Med J (Engl); 1988 Jul; 101(7):513-6. PubMed ID: 3147850
[No Abstract] [Full Text] [Related]
27. Can hybrid SPECT-CT overcome the limitations associated with poor imaging properties of 131I-MIBG?: Comparison with planar scintigraphy and SPECT in pheochromocytoma.
Sharma P; Dhull VS; Jeph S; Reddy RM; Singh H; Naswa N; Bal C; Kumar R
Clin Nucl Med; 2013 Sep; 38(9):e346-53. PubMed ID: 23510889
[TBL] [Abstract][Full Text] [Related]
28. [Nuclear medicine diagnosis of pheochromocytoma with metaiodobenzylguanidine].
Pucar D; Marković S
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():20-4. PubMed ID: 12584993
[TBL] [Abstract][Full Text] [Related]
29. [A comparison of scintigraphy with radioiodinated MIBG and CT in localizing pheochromocytomas].
Rufini V; Troncone L; Valentini AL; Danza FM
Radiol Med; 1988 Nov; 76(5):466-70. PubMed ID: 3205923
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis of pheochromocytoma using [123I]-compared with [131I]-metaiodobenzylguanidine scintigraphy.
Furuta N; Kiyota H; Yoshigoe F; Hasegawa N; Ohishi Y
Int J Urol; 1999 Mar; 6(3):119-24. PubMed ID: 10226821
[TBL] [Abstract][Full Text] [Related]
31. Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases.
Shapiro B; Copp JE; Sisson JC; Eyre PL; Wallis J; Beierwaltes WH
J Nucl Med; 1985 Jun; 26(6):576-85. PubMed ID: 2860214
[TBL] [Abstract][Full Text] [Related]
32. Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues.
Khafagi FA; Shapiro B; Fig LM; Mallette S; Sisson JC
J Nucl Med; 1989 Apr; 30(4):481-9. PubMed ID: 2738677
[TBL] [Abstract][Full Text] [Related]
33. False-positive diagnosis of adrenal pheochromocytoma on iodine-123-MIBG scan.
Letizia C; De Toma G; Massa R; Corsi A; Caliumi C; Subioli S; D'Erasmo E
J Endocrinol Invest; 1998 Dec; 21(11):779-83. PubMed ID: 9972680
[TBL] [Abstract][Full Text] [Related]
34. Iodine-131 MIBG imaging in multiple endocrine neoplasia type 2B.
Yamamoto Y; Isobe Y; Nishiyama Y; Takashima H; Ohkawa M; Kihara M; Matsusaka K; Miyauchi A; Kobayashi S; Tanabe M
Clin Nucl Med; 1998 Jan; 23(1):13-5. PubMed ID: 9442958
[TBL] [Abstract][Full Text] [Related]
35. Clinical use and utility of metaiodobenzylguanidine scintigraphy in pheochromocytoma diagnosis.
Lev I; Kelekar G; Waxman A; Yu R
Endocr Pract; 2010; 16(3):398-407. PubMed ID: 20061293
[TBL] [Abstract][Full Text] [Related]
36. [Adrenomedullary scintigraphy with I-131 metaiodobenzylguanidine].
Ohta Y; Takahashi E; Matsumoto Y; Kawasaki Y; Maki M; Hiroe D; Kusakabe K
Rinsho Hoshasen; 1985 Mar; 30(3):399-400. PubMed ID: 4021133
[No Abstract] [Full Text] [Related]
37. Brown fat imaging with (18)F-6-fluorodopamine PET/CT, (18)F-FDG PET/CT, and (123)I-MIBG SPECT: a study of patients being evaluated for pheochromocytoma.
Hadi M; Chen CC; Whatley M; Pacak K; Carrasquillo JA
J Nucl Med; 2007 Jul; 48(7):1077-83. PubMed ID: 17574980
[TBL] [Abstract][Full Text] [Related]
38. [131I-meta-iodobenzylguanidine scintigraphy in patients with a suspected pheochromocytoma. A comparison with CT and biohumoral parameters].
Maurelli L; Cuocolo A; Lastoria S; Brunetti A; Maurea S; Lembo G; Klain M; Caracò C; Salvatore M
Radiol Med; 1991 Dec; 82(6):839-43. PubMed ID: 1788441
[TBL] [Abstract][Full Text] [Related]
39. Thallium-201 scintigraphy in the diagnosis of pheochromocytoma.
Wenisch HJ; Maul FD; Happ J; Schumm PM; Bittner G; Wanner U; Hör G; Encke A
Cardiology; 1985; 72 Suppl 1():150-2. PubMed ID: 4053122
[TBL] [Abstract][Full Text] [Related]
40. Use of 131I-MIBG scintigraphy in the evaluation of suspected pheochromocytoma.
Swensen SJ; Brown ML; Sheps SG; Sizemore GW; Gharib H; Grant CS; van Heerden JA
Mayo Clin Proc; 1985 May; 60(5):299-304. PubMed ID: 3990377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
